So we are all aware of the upcoming trials by Advanced Cell Technology to see whether Stargardt's and also Dry Age Related Macular Degeneration can be treated with embryonic stem cells. ACT released more information a few days ago about the upcoming trials involving 12 patients for each condition.
The phase of the study isn't actually testing whether using the stem cells will have any benefit, rather on the safety of using such technology.
The am of the treatment is to replace the malfunctioning RPE cells in the macular with functioning cells to halt the damage being done.
Hopefully the first phrase of the trials are successful and safe, with minimal harm being placed on the brave Stargardt's patients being involved.
Check out more information on the links below.
UK Mail online